Tumor News and Research

RSS

Researchers describe mechanism linking HPV infection and cancer

Infection with human papillomavirus (HPV) is the primary cause of cervical cancer and a subset of head and neck cancers worldwide.

23 Aug 2017

Study findings could one day help doctors better predict survival of liver cancer patients

A new study of a molecule that regulates liver-cell metabolism and suppresses liver-cancer development shows that the molecule interacts with thousands of genes in liver cells, and that when levels of the molecule go down, which often happens during liver-cancer development, the activity of certain cancer-promoting genes goes up.

23 Aug 2017

New blood test can predict drug resistance in patients with advanced prostate cancer

When bacteria develop antibiotic resistance, treatment with these medications becomes ineffective. Similarly, tumor cells can also change in such a way that renders them resistant to particular medications.

22 Aug 2017

Study reveals possible medical and industrial properties of avocado seed husks

A new study presented at the 254th National Meeting & Exposition of the American Chemical Society (ACS), suggests that avocado seed husks contain a treasure of unidentified chemical compounds which has the potential to be used in treating various debilitating diseases such as, cancer and heart diseases, as well as in enhancing perfumes, cosmetics and other consumer goods.

22 Aug 2017

Female patients with esophageal cancer have superior response to treatment, study reveals

Female patients with locally advanced esophageal cancer that is treated with chemotherapy and radiation therapy before surgery are more likely to have a favorable response to the treatment than male patients are, and women are less likely to experience cancer recurrence, according to a study published online today in The Annals of Thoracic Surgery.

22 Aug 2017

Novel nanolaser can serve as super-bright probe to detect and kill metastasized cancer cells

A nanolaser known as the spaser can serve as a super-bright, water-soluble, biocompatible probe capable of finding metastasized cancer cells in the bloodstream and then killing these cells, according to a new research study.

22 Aug 2017

MUSC researchers show how non-coding RNA promotes tumor formation

A mechanism that pushes a certain gene to produce a non-coding form of RNA instead of its protein-coding alternative can promote the growth of cancer, report researchers at the Medical University of South Carolina in an article published online ahead of print on August 21, 2017 by Nature Cell Biology.

22 Aug 2017

Review of kidney cancer incidence in California signals end of a trend

A review of kidney cancer in California from 1988 through 2013 by the UC Davis Institute for Population Health Improvement has concluded that the high incidence of small tumors and early-stage disease observed in California from 1988 until about 2009 has declined and stabilized in recent years, signaling the end of a trend.

18 Aug 2017

Combination treatment effectively vaccinates mice against cancer

By combining an FDA-approved cancer immunotherapy with an emerging tumor-roasting nanotechnology, Duke University researchers improved the efficacy of both therapies in a proof-of-concept study using mice.

18 Aug 2017

New research suggests cell immortalization as more complicated process than originally thought

A mutation that helps make cells immortal is critical to the development of a tumor, but new research at the University of California, Berkeley suggests that becoming immortal is a more complicated process than originally thought.

18 Aug 2017

Research identifies new gene fusions and mutations linked to GIST tumors

Researchers at UC San Diego Moores Cancer Center, with colleagues from Memorial Sloan Kettering Cancer Center and Fox Chase Cancer Center, have determined that a specific region of the small bowel, called the duodenal-jejunal flexure or DJF, shows a high frequency of gastrointestinal stromal tumors (GISTs) with mutations of the NF1 gene

18 Aug 2017

Drug-like molecule appears to interfere with inflammatory response in variety of diseases

A drug-like molecule developed by Duke Health researchers appears to intercede in an inflammatory response that is at the center of a variety of diseases, including some cancers, rheumatoid arthritis and Crohn's disease.

17 Aug 2017

High-definition eye scan could reveal crucial warning signs of Alzheimer's disease

Cedars-Sinai neuroscience investigators have found that Alzheimer's disease affects the retina – the back of the eye – similarly to the way it affects the brain.

17 Aug 2017

Researchers get closer to creating new blood test that can identify breast cancer brain metastasis

Houston Methodist cancer researchers are now closer to creating a blood test that can identify breast cancer patients who are at increased risk for developing brain metastasis, and also monitor disease progression and response to therapy in real time.

17 Aug 2017

Research provides clues to how infectious bacteria may increase risk of cancer

Gastric carcinoma is one of the most common causes of cancer-related deaths, primarily because most patients present at an advanced stage of the disease.

17 Aug 2017

Preclinical research using 1 Tesla desktop MRI

An interview with Dr. Ichio Aoki, National Institutes for Quantum and Radiological Science and Technology.

From Bruker BioSpin - NMR, EPR and Imaging 17 Aug 2017

Novel blood test identifies tumor-derived DNA in early-stage cancer patients

In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to accurately identify more than half of 138 people with relatively early-stage colorectal, breast, lung and ovarian cancers.

17 Aug 2017

Sanford Health launches solid tumor oncolytic virus clinical trial

Sanford Health is the first site in the United States to launch a clinical trial using a genetically-engineered virus that aims to destroy therapy-resistant tumors.

17 Aug 2017

Immunotherapy drug shows favorable safety profile in patients with advanced small cell lung cancer

The immunotherapy drug pembrolizumab has demonstrated a favorable safety profile and "promising durable clinical activity" in pretreated patients who exhibit high levels of the PD-L1 protein in advanced stages of small cell lung cancer (SCLC) – an aggressive form of the disease

16 Aug 2017

Chapman University's School of Pharmacy wins more than $3.5 million through 30 research awards

Chapman University’s four-year-old School of Pharmacy continues its aggressive growth in federal grant awards.

16 Aug 2017

Tumor News and Research

Researchers describe mechanism linking HPV infection and cancer

Study findings could one day help doctors better predict survival of liver cancer patients

New blood test can predict drug resistance in patients with advanced prostate cancer

Study reveals possible medical and industrial properties of avocado seed husks

Female patients with esophageal cancer have superior response to treatment, study reveals

Novel nanolaser can serve as super-bright probe to detect and kill metastasized cancer cells

MUSC researchers show how non-coding RNA promotes tumor formation

Review of kidney cancer incidence in California signals end of a trend

Combination treatment effectively vaccinates mice against cancer

New research suggests cell immortalization as more complicated process than originally thought

Research identifies new gene fusions and mutations linked to GIST tumors

Drug-like molecule appears to interfere with inflammatory response in variety of diseases

High-definition eye scan could reveal crucial warning signs of Alzheimer's disease

Researchers get closer to creating new blood test that can identify breast cancer brain metastasis

Research provides clues to how infectious bacteria may increase risk of cancer

Preclinical research using 1 Tesla desktop MRI

Novel blood test identifies tumor-derived DNA in early-stage cancer patients

Sanford Health launches solid tumor oncolytic virus clinical trial

Immunotherapy drug shows favorable safety profile in patients with advanced small cell lung cancer

Chapman University's School of Pharmacy wins more than $3.5 million through 30 research awards

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News